Digital Millennium Copyright Act (“DMCA”)
PharmaTech News respects the intellectual property rights of others. Per the DMCA, PharmaTech News will respond expeditiously to claims of copyright infringement on the Site if submitted to PharmaTech News’s Copyright Agent as described below. Upon receipt of a notice alleging copyright infringement, PharmaTech News will take whatever action it deems appropriate within its sole discretion, including removal of the allegedly infringing materials and termination of access for repeat infringers of copyright protected content.
If you believe that your intellectual property rights have been violated by PharmaTech News or by a third party who has uploaded materials to our website, please provide the following information to the designated Copyright Agent listed below:
- A description of the copyrighted work or other intellectual property that you claim has been infringed;
- A description of where the material that you claim is infringing is located on the Site;
- An address, telephone number, and email address where we can contact you and, if different, an email address where the alleged infringing party, if not Her Forward, can contact you;
- A statement that you have a good-faith belief that the use is not authorized by the copyright owner or other intellectual property rights owner, by its agent, or by law;
- A statement by you under penalty of perjury that the information in your notice is accurate and that you are the copyright or intellectual property owner or are authorized to act on the owner’s behalf;
- Your electronic or physical signature.
PharmaTech News may request additional information before removing any allegedly infringing material. In the event PharmaTech News removes the allegedly infringing materials, PharmaTech News will immediately notify the person responsible for posting such materials that PharmaTech News removed or disabled access to the materials. PharmaTech News may also provide the responsible person with your email address so that the person may respond to your allegations.
Pursuant to 17 U.S.C. 512(c). PharmaTech News designated Copyright Agent is: